Molecular Partners AG MOLN
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -6.28% | -9.13% | -4.79% | -17.11% | -10.32% |
| Gross Profit | 6.28% | 9.13% | 4.79% | 11.57% | -1.74% |
| SG&A Expenses | 4.07% | 8.63% | -7.83% | -11.61% | -1.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.47% | -4.49% | -5.89% | -15.53% | -8.06% |
| Operating Income | 3.47% | 4.49% | 5.89% | 11.58% | -0.87% |
| Income Before Tax | 30.59% | 10.12% | -23.77% | 21.98% | -48.26% |
| Income Tax Expenses | -- | -- | 117.39% | -- | -- |
| Earnings from Continuing Operations | 30.59% | 10.11% | -23.79% | 21.98% | -48.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.59% | 10.11% | -23.79% | 21.98% | -48.26% |
| EBIT | 3.47% | 4.49% | 5.89% | 11.58% | -0.87% |
| EBITDA | 3.27% | 4.79% | 5.99% | 11.92% | -0.88% |
| EPS Basic | 32.24% | 11.62% | -22.03% | 30.77% | -31.58% |
| Normalized Basic EPS | 22.26% | 11.61% | -22.43% | 31.45% | -14.71% |
| EPS Diluted | 32.24% | 11.62% | -21.30% | 30.77% | -31.58% |
| Normalized Diluted EPS | 22.26% | 11.61% | -22.43% | 31.45% | -14.71% |
| Average Basic Shares Outstanding | 2.44% | 1.70% | 1.44% | 12.67% | 12.69% |
| Average Diluted Shares Outstanding | 2.44% | 1.70% | 1.44% | 12.67% | 12.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |